Overview

Safety and Effectiveness of Acthar Gel for Inflammation of the Eye's Uvea (Middle Layer)

Status:
Terminated
Trial end date:
2020-07-14
Target enrollment:
Participant gender:
Summary
The main reason for this study is to see if Acthar Gel can reduce inflammation in the uvea. Also, safety information when using it for this purpose will be collected.
Phase:
Phase 4
Details
Lead Sponsor:
Mallinckrodt
Treatments:
Adrenocorticotropic Hormone